Page 41 - Revista Argentina de Transfusión 1 - 2020
P. 41

linked disorders. Nature Reviews Molecular Cell Biology 2008;  49. Edgerton VR, Ohira Y, Hettiarachchi J, et al.: Elevation of
               9: 72-81                                            hemoglobin and work tolerance in iron-deficient subjects. J
            30. Punnonen K, Irjala K, RajamakiA.Serum transferrin receptor  Nutr Sci Vitaminol (Tokyo) 1981; 27:77–86
               and its ratio to serum ferritin in the diagnosis of iron defi-  50. Ekiz C, Agaoglu L, Karakas Z, et al.: The effect of iron deficiency
               ciency. Blood 1997;89:1052-7.                       anemia on the function of the immune system. Hematol J 2005;
            31. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a  5:579–583
               quantitative measure of tissue iron deficiency. Blood, 1990;  51. Oppenheimer SJ: Iron and its relation to immunity and infec-
               75:1870-1876.                                       tious disease. J Nutr 2001; 131:616S–633S
            32. Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as  52. Rigas AS, Sørensen CJ, Pedersen OB, Petersen MS, Thørner
               a new index of erythropoiesis. Blood, 1987;70:1955-1958  LW, Kotze´ S, et al. Predictors of iron levels in 14, 737 Danish
            33. Kolbe-Busch S, Lotz J, Hafner G, Blanckaert NJ, Claeys G, Togni  blood donors: results from the Danish Blood Donor Study. Trans-
               G, Carlsen J, Röddiger R, Thomas L. Multicenter evaluation of a  fusion. 2014; 54: 789–796. https://doi.org/10.1111/trf.12518
               fully mechanized soluble transferrin receptor assay on the  PMID: 24372094
               Hitachi and cobas integra analyzers. The determination of ref-  53. Salvin HE, Pasricha SR, Marks DC, Speedy J. Iron deficiency in
               erence ranges. Clin Chem Lab Med. 2002 May;40(5):529-36.  blood donors: A national cross-sectional study. Transfusion.
            34. Carriaga MT, Skikne BS, Cutler B, et al. Serum transferrin  2014; 54: 2434–2444. https://doi.org/10.1111/trf.12647 PMID:
               receptor for the detection of iron deficiency in pregnancy. Ameri-  24738792
               can Journal of Clinical Nutrition, 1991,54:1077-1081  54. Goldman M, Uzicanin S, Osmond L, Scalia V, O’Brien SF. A large
            35. Kogho Y, Nishisato T, Kondo H, et al. Circulating transferrin  national study of ferritin testing in Canadian blood donors. Trans-
               receptor in human serum. British Journal of Haematology, 1986,  fusion. 2017; 57: 564–570. https://doi.org/10.1111/trf.13956
               64:277-281.                                         PMID: 27943371
            36. Parmley RT, May ME, Spicer SS, Buse MG, Alvarez CJ. Ultrastruc-  55. Baart AM, Van Noord PAH, Vergouwe Y, Moons KGM, Swinkels
               tural distribution of inorganic iron in normal and iron-loaded  DW, Wiegerinck ET, et al. High prevalence of subclinical iron
               hepatic cells. Lab Invest. 1981 May;44(5):475-85.   deficiency in whole blood donors not deferred for low
            37. Provan D. Mechanisms and management of iron deficiency  hemoglobin. Transfusion. 2013; 53: 1670–1677. https://doi.org/
               anaemia. Br J Haematol 1999;105 Suppl1:19-26        10.1111/j.1537-2995.2012.03956.x PMID: 23176175
            38. Murphy JF, O’Riordan J, Newcombe RG, et al.: Relation of hae-  56. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL,
               moglobin levels in first and second trimesters to outcome of  et al. Iron deficiency in blood donors: The REDS-II Donor Iron
               pregnancy. Lancet 1986; 1:992–995                   Status Evaluation (RISE) study. Transfusion. 2012; 52: 702–
            39. Zhou LM, Yang WW, Hua JZ, et al.: Relation of hemoglobin  711.
               measured at different times in pregnancy to preterm birth and  57. Kiss JE, Birch RJ, Steele WR, Wright DJ, Cable RG. Quantifica-
               low birth weight in Shanghai, China. Am J Epidemiol 1998;  tion of body iron and iron absorption in the REDS-II Donor Iron
               148:998–1006                                        Status Evaluation (RISE) study. Transfusion. 2017; 57(7):1656–
            40. Radlowski EC, Johnson RW: Perinatal iron deficiency and  64.
               neurocognitive development. Front Hum Neurosci 2013; 7:585  58. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood
            41. Rytych JL, Elmore MR, Burton MD, et al.: Early life iron defi-  donors: analysis of enrollment data from the REDS-II Donor
               ciency impairs spatial cognition in neonatal piglets. J Nutr 2012;  Iron Status Evaluation (RISE) study. Transfusion 2011;51:511-
               142:2050–2056                                       22.
            42. Georgieff MK: The role of iron in neurodevelopment: fetal iron  59. Goldman M, Uzicanin S, Scalia V, O'Brien SF. Iron deficiency in
               deficiency and the developing hippocampus. Biochem Soc Trans  Canadian blood donors. Transfusion 2013; 54: 775-9.
               2008; 36:1267–1271                                60. Semmelrock MJ, Raggam RB, Amrein K, et al. Reticulocyte
            43. Rytych JL, Elmore MR, Burton MD, et al.: Early life iron defi-  hemoglobin content allows early and reliable detection of func-
               ciency impairs spatial cognition in neonatal piglets. J Nutr 2012;  tional iron deficiency in blood donors Clin Chim Acta 2012; 413:
               142:2050–2056                                       678-82.
            44. McEchron MD, Cheng AY, Liu H, et al.: Perinatal nutritional iron  61. Rigas AS, Pedersen OB, Sørensen CJ, et al. No association
               deficiency permanently impairs hippocampus-dependent trace  between iron status and self-reported health-related quality of
               fear conditioning in rats. Nutr Neurosci 2005; 8:195–206  life in 16,375 Danish blood donors: results from the Danish
            45. Yehuda S, Youdim MB: Brain iron: a lesson from animal mod-  Blood Donor Study. Transfusion 2015; 55: 1752-6.
               els. Am J Clin Nutr 1989; 50:618–625;             62. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy
            46. Lozoff B, Jimenez E, Hagen J, et al.: Poorer behavioral and  EL, et al. Demographic correlates of low hemoglobin deferral
               developmental outcome more than 10 years after treatment  among prospective whole blood donors. Transfusion
               for iron deficiency in infancy. Pediatrics 2000; 105:E51  2010;50:1794802.
            47. Vaucher P, Druais PL, Waldvogel S, et al.: Effect of iron supple-  63. Annen K, Delaney M, Leitch D, Mast AE. The health implica-
               mentation on fatigue in nonanemic menstruating women with  tions of low hemoglobin deferral in infrequent blood donors.
               low ferritin: a randomized controlled trial. CMAJ 2012;  Transfusion 2015;55:8690.
               184:1247–1254                                     64. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The
            48. Krayenbuehl PA, Battegay E, Breymann C, et al.: Intravenous  consequences of temporary deferral on future whole blood do-
               iron for the treatment of fatigue in nonanemic, premenopausal  nation. Transfusion 2007;47:151423.
               women with low serum ferritin concentration. Blood 2011;  65. Halperin D, Baetens J, Newman B. The effect of shortterm,
               118:3222–3227                                       temporary deferral on future blood donation. Transfusion

             Anemia ferropénica en donantes de sangre  Vol. XLVI / N° 1 / 2020             Asociación Argentina  Pág. 35
                                                   Págs. 25 / 38                           de Hemoterapia,
                                                                                           Inmunohematología
                                                                                           y Terapia Celular
   36   37   38   39   40   41   42   43   44   45   46